Difference between revisions of "Normative:SARS-CoV-2"
(Created page with "==Normative== === Spelling variants === ===Synonyms=== * ===Definition=== Source: === Encyclopaedic information === Source: ===Examples=== '''1)''' Source: ===Collocat...") |
(changes to the normative section) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
==Normative== | ==Normative== | ||
=== | === Definition === | ||
Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a newly emergent coronavirus, that was first recognized in Wuhan, Hubei province, China, in December 2019. SARS-CoV-2 is a positive-sense single-stranded RNA virus that is contagious in humans. It is the successor to SARS-CoV-1, the strain that caused the 2002–2004 SARS outbreak. | |||
<small>Source:</small> <small>https://apps.who.int/iris/handle/10665/338882</small> | |||
Source: | |||
=== Encyclopaedic information === | === Encyclopaedic information === | ||
Source: | On 30 January 2020, the Director-General of the World Health Organization (WHO) declared a public health emergency of international concern over the global outbreak of severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ), which causes coronavirus disease 2019 (COVID-19). | ||
<small>Source:</small> <small>https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32021R0953</small> | |||
===Examples=== | ===Examples=== | ||
''' | <blockquote>Illness was confirmed by a positive result on a '''SARS-CoV-2''' molecular test. </blockquote><small>Source: https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf</small> | ||
===Collocations=== | |||
* viable SARS-CoV-2 | |||
* persistent SARS-CoV-2 | |||
* SARS-CoV-2 infection | |||
* SARS-CoV-2 variant | |||
* SARS-CoV-2 vaccine | |||
* SARS-CoV-2 transmission | |||
* SARS-CoV-2 vaccination | |||
* SARS-CoV-2 vaccine | |||
* SARS-CoV-2 antibodies | |||
* SARS-CoV-2 testing | |||
* SARS-CoV-2 clearance | |||
* SARS-CoV-2 PEP | |||
* SARS-CoV-2 pneumonia | |||
* SARS-CoV-2 RNA | |||
* SARS-CoV-2 replication | |||
* SARS-CoV-2 reinfection | |||
* to dedect SARS-CoV-2 | |||
* to transmit SARS-CoV-2 | |||
* to target SARS-CoV-2 | |||
* to inhibit SARS-CoV-2 | |||
* to identify SARS-CoV-2 | |||
* | * | ||
===Keyness=== | ===Keyness=== | ||
1 | |||
Latest revision as of 17:10, 20 February 2022
Normative
Definition
Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a newly emergent coronavirus, that was first recognized in Wuhan, Hubei province, China, in December 2019. SARS-CoV-2 is a positive-sense single-stranded RNA virus that is contagious in humans. It is the successor to SARS-CoV-1, the strain that caused the 2002–2004 SARS outbreak.
Source: https://apps.who.int/iris/handle/10665/338882
Encyclopaedic information
On 30 January 2020, the Director-General of the World Health Organization (WHO) declared a public health emergency of international concern over the global outbreak of severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ), which causes coronavirus disease 2019 (COVID-19).
Source: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32021R0953
Examples
Illness was confirmed by a positive result on a SARS-CoV-2 molecular test.
Source: https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf
Collocations
- viable SARS-CoV-2
- persistent SARS-CoV-2
- SARS-CoV-2 infection
- SARS-CoV-2 variant
- SARS-CoV-2 vaccine
- SARS-CoV-2 transmission
- SARS-CoV-2 vaccination
- SARS-CoV-2 vaccine
- SARS-CoV-2 antibodies
- SARS-CoV-2 testing
- SARS-CoV-2 clearance
- SARS-CoV-2 PEP
- SARS-CoV-2 pneumonia
- SARS-CoV-2 RNA
- SARS-CoV-2 replication
- SARS-CoV-2 reinfection
- to dedect SARS-CoV-2
- to transmit SARS-CoV-2
- to target SARS-CoV-2
- to inhibit SARS-CoV-2
- to identify SARS-CoV-2
Keyness
1